Webb13 apr. 2024 · Recently, more and more polymer microsphere formulations have been approved by the U.S. FDA and some of them are approved via 505(b)(2) pathway. A few examples are displayed in Table 6. For instance, LUTRATE DEPOT is a sterile PLGA microsphere-based formulation to treat the symptoms of Advanced Prostate Cancer, … Webb6 jan. 2024 · Objective: This study aims to study the preparation method of arsenic trioxide (As2O3) polylactic-co-glyconlic acid (PLGA) microspheres and 10-hydroxycamptothecin …
Chun-Yu (Delphine) Lin - Research Assistant - LinkedIn
http://www.nanoparticles.org/EMU/SurfMod/Wk12/JCR-05-102-313.pdf Webb1 juli 2010 · OBJECTIVE: To prepare PLGA microsphere of BSP. METHODS: mulsion solvent extraction-evaporation process was used to prepare microsphere. Technology of preparation was optimized by the orthogonal design. The surface morphology of the microsphere was observed by EM and SEM. biltmore ear nose and throat
Preparation, Characterization and in vitro/in vivo Evaluation of ...
WebbPoly(lactic-co-glycolic acid) (PLGA) is an of the preferred polymeric inactive ingredients for long-acting parenteral medical products that are constituted of complex formulations. Despite over 30 years of use, there are even many challenges faced until researchers in formulation-related elements pertaining to drug loading and unlock. Pending now, PLGA … WebbPLGA, PLG, or poly (lactic-co-glycolic ... Common catalysts used in the preparation of this polymer include tin(II) 2-ethylhexanoate, tin(II) alkoxides, or aluminum isopropoxide. ... It … Webb28 juni 2016 · Strategies for increasing drug loading in PLGA-microspheres include modification of the classical solvent evaporation methods, preparation of multi-layered microparticles, and development of novel methods for microparticle fabrication including hydrogel templates, coaxial electrospray, microfluidics, and scCO 2. biltmore during the holidays